Item Type | Name |
Concept
|
Transplantation, Homologous
|
Academic Article
|
Liver biopsy interpretation for causes of late liver allograft dysfunction.
|
Academic Article
|
Tolerogenic immunosuppression for organ transplantation.
|
Academic Article
|
Cotransplanted hepatic stellate cells enhance vascularization of islet allografts.
|
Academic Article
|
Chimerism after organ transplantation.
|
Academic Article
|
Combined liver-kidney transplants: allosensitization and recipient outcomes.
|
Academic Article
|
Human islet isolation and allotransplantation in 22 consecutive cases.
|
Academic Article
|
Management of intestinal transplantation in humans.
|
Academic Article
|
Immunopathology of antibodies as effectors of orthotopic liver allograft rejection.
|
Academic Article
|
Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences.
|
Academic Article
|
A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection.
|
Academic Article
|
Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
|
Academic Article
|
Experience with liver and kidney allografts from non-heart-beating donors.
|
Academic Article
|
Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model.
|
Academic Article
|
Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
|
Academic Article
|
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
|
Academic Article
|
Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants.
|
Academic Article
|
FK 506 used as rescue therapy for human liver allograft recipients.
|
Academic Article
|
Clinical intestinal transplantation.
|
Academic Article
|
Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
|
Academic Article
|
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts.
|
Academic Article
|
Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
|
Academic Article
|
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides.
|
Academic Article
|
Human islet allotransplantation under FK 506.
|
Academic Article
|
Clinical small bowel or small bowel plus liver transplantation under FK 506.
|
Academic Article
|
Infusion of donor leukocytes to induce tolerance in organ allograft recipients.
|
Academic Article
|
In vivo immune modulatory activity of hepatic stellate cells in mice.
|
Academic Article
|
Real-time monitoring of acute liver-allograft rejection using the Banff schema.
|
Academic Article
|
Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers.
|
Academic Article
|
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.
|
Academic Article
|
Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts.
|
Academic Article
|
Central venulitis in the allograft liver: a clinicopathologic study.
|
Academic Article
|
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
|
Academic Article
|
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.
|
Academic Article
|
First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries.
|
Academic Article
|
Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice.
|
Academic Article
|
Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.
|
Academic Article
|
Concordant hamster-to-rat liver xenotransplantation leads to hyperlipidemia.
|
Academic Article
|
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival.
|
Academic Article
|
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection.
|
Academic Article
|
ICAM-1 expressed on hepatic stellate cells plays an important role in immune regulation.
|
Academic Article
|
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation.
|
Academic Article
|
The long-term efficacy of multivisceral transplantation.
|
Academic Article
|
Five-year experience with tacrolimus rescue for renal allograft rejection.
|
Academic Article
|
Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts.
|
Academic Article
|
The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion.
|
Academic Article
|
Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats.
|
Academic Article
|
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
|
Academic Article
|
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
|
Academic Article
|
Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts.
|
Academic Article
|
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Academic Article
|
Revascularization of the gastroduodenal artery in a pancreas allograft from a donor with a replaced right hepatic artery.
|
Academic Article
|
Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
|
Academic Article
|
Cytokine profile in graft-versus-host disease after small bowel transplantation.
|
Academic Article
|
The effect of thymus transplantation on allograft rejection in thymectomized bone marrow chimeras.
|
Academic Article
|
Liver allograft rejection: an overview of morphologic findings.
|
Academic Article
|
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts.
|
Academic Article
|
Intestinal transplantation for patients with short gut syndrome and hypercoagulable states.
|
Academic Article
|
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption.
|
Academic Article
|
Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506.
|
Academic Article
|
Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.
|
Academic Article
|
[Experience of orthotopic liver transplantation from non-heart-beating donors at the University of Pittsburgh Medical Center].
|
Academic Article
|
Perioperative donor bone marrow infusion in recipients of organ allografts.
|
Academic Article
|
Transfection with genes encoding CTLA4Ig mediated by adenoassociated virus vectors prolongs survival of heart allografts.
|
Academic Article
|
Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro.
|
Academic Article
|
Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts.
|
Academic Article
|
Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses.
|
Academic Article
|
The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us?
|
Academic Article
|
Clinical intestinal transplantation: new perspectives and immunologic considerations.
|
Academic Article
|
Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection.
|
Academic Article
|
Posttransplant lymphoproliferative disorders in small bowel allograft recipients.
|
Academic Article
|
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years.
|
Academic Article
|
Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation.
|
Academic Article
|
Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
|
Academic Article
|
Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice.
|
Academic Article
|
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.
|
Academic Article
|
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats.
|
Academic Article
|
Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation.
|
Academic Article
|
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
|
Academic Article
|
Quality of life after intestinal transplantation and on total parenteral nutrition.
|
Academic Article
|
Long-term nutritional monitoring after clinical intestinal transplantation.
|
Academic Article
|
Split tolerance induced by orthotopic liver transplantation in mice.
|
Academic Article
|
Evidence for early Th 2 T cell predominance in xenoreactivity.
|
Academic Article
|
Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses.
|
Academic Article
|
Histologic monitoring of human small bowel allografts with clinical correlation.
|
Academic Article
|
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies.
|
Academic Article
|
Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience.
|
Academic Article
|
Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58.
|
Academic Article
|
Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells.
|
Academic Article
|
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
|
Academic Article
|
Percutaneous ultrasound-guided pancreas allograft biopsy: a single-center experience.
|
Academic Article
|
Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients.
|
Academic Article
|
Nutritional management of intestinal allograft recipients.
|
Academic Article
|
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
|
Academic Article
|
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions.
|
Academic Article
|
Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience.
|
Academic Article
|
Expanding the donor pool: safe transplantation of a cadaveric liver allograft with a 10 cm cavernous hemangioma--a case report.
|
Academic Article
|
Glucose balance of porcine liver allograft is an important predictor of outcome.
|
Academic Article
|
Murine liver allograft transplantation: tolerance and donor cell chimerism.
|
Academic Article
|
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
|
Academic Article
|
FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats.
|
Academic Article
|
FK 506 dosage in human organ transplantation.
|
Academic Article
|
Near-total human face transplantation for a severely disfigured patient in the USA.
|
Academic Article
|
Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage.
|
Academic Article
|
Detection of intrahepatic human islets following combined liver-islet allotransplantation.
|
Academic Article
|
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
|
Academic Article
|
Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway.
|
Academic Article
|
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization.
|
Academic Article
|
Bacterial translocation in clinical intestinal transplantation.
|
Academic Article
|
The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis.
|
Academic Article
|
The immunolymphatic theory of chronic rejection.
|
Academic Article
|
Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
|
Academic Article
|
C-C Chemokine Receptor Type 2-Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants.
|